REG - Compagnie St-Gobain - Prospectus Supplement

Compagnie de Saint Gobain SAAnnouncement

24/08/2018 17:25

RNS Number : 8803Y
Compagnie de Saint-Gobain
24 August 2018
 



 
PUBLICATION OF PROSPECTUS SUPPLEMENT
 
Compagnie de Saint-Gobain, société anonyme with registered office at Les Miroirs, 18, avenue d'Alsace, 92400 Courbevoie, France (the Issuer).
The following prospectus supplement has been approved by the United Kingdom Listing Authority (the UKLA) and is available for viewing:
Prospectus supplement n° 1 (the Prospectus Supplement) dated 24 August 2018, supplementing the base prospectus dated 13 July 2018, for the Issuer's EUR15,000,000,000 medium term note programme.
A copy of the Prospectus Supplement has been submitted to the National Storage Mechanism and is available for inspection at: www.Hemscott.com/nsm.do.
To view the full document, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/8803Y_1-2018-8-24.pdf
 
 
For further information, please contact:
Vivien Dardel
Compagnie de Saint-Gobain
Tel. + 33 1 47 62 44 29
 
 
 
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus Supplement may be addressed to and/or targeted at persons who are particular types of investors and residents of particular countries only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus Supplement is not addressed. Prior to relying on the information contained in the Prospectus Supplement you must ascertain from the Prospectus Supplement whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPUSANRWNAWUAR